Summary
The efficacy of Shosaiko-to (SST) on 222 patients with chronic active hepatitis was studied in a double-blind multicenter clinical study. One hundred and sixteen patients received SST in a daily oral dose of 5.4 g for 12 weeks, followed by the same dose for a further 12 weeks. One hundred and six patients received a placebo containing 0.5 g of SST for 12 weeks, followed by a cross-over to SST for a further 12 weeks. Among the liver tests, serum AST and ALT values decreased significantly with the admisnistration of SST. The difference of the mean value between the SST group and the placebo group was significant after 12 weeks. In patients with chronic active type B hepatitis, a tendency towards a decrease of HBeAg and an increase of Anti-HBe antibodies was also observed. No remarkable side effects were noticed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Yamamoto M, Kumagai A, Yamamura Y: Structure and actions of saikosaponins isolated from Bupleurum falcatum L.I. Anti-inflammatory action of saikosaponins. Arzneim Forsch 1975;25:102M023
Abe H, Sakaguchi M, Odashima S, et al: Protective effect of saikosaponin-d isolated from Bupleurum falcatum L. on CC14-induced liver injury in the rat. Naunyn Schmiedebergs Arch Pharmacol 1982;320:266–271
Kawakita T, Yamada A, Kumazawa Y, et al: Accumulation of immature B and null lymphocytes in the periphery after intraperitoneal administration of traditional Chinese medicine, Xiao-Chai-Hu-Tang (Japanese name: Shosaiko-To). J Immunopharmacol 1986;8:561–588
Kumazawa Y, Takimoto H, Miura S, et al: Activation of murine peritoneal macrophages by intraperitoneal administration of a traditional Chinese hebral medicine, Xiao-ChaiHu-Tang (Japanese name: Shosaiko-To). Int J Immunopharmacol 1988;10:395–403
Mizuta M, Murata K, Morimoto T, et al: Therapeutical evaluation of Shosaiko-to on chronic hepatitis-Study on double-Wine test -. Kan Tan Sui 1986;12:155–168 (in Jpn)
Mushawar IK, Overby LR, Frosner G, et al: Prevalence of hepatitis B e-entigen and e-antibody and its antibody as detected by radioimmunoassays. J Med Virol 1978;2:77–87
Suzuki H, Yamamoto S, Hirayama C, et al: Cianidanol therapy for HBe-antigen-positive chronic hepatitis: a multicentre, double-blind study. Liver 1986;6:35–44
Abe H, Sakaguchi M, Anno M, et al: Erythrocyte membrane stabilization by plant saponins and sapogenins. Naunyn Schniedebergs Arch Pharmacol 1981;316:262–265
Ikemoto Y, Mizoguchi Y, Arai T, et al: Effects of Shosaiko-To (Xiao-Chai-Hu-Tang) and Daisaiko-To (Da-Chai-Hu-Tang) on antibody response in vitro. J Med Soc Wakan-yaku 1984;1:235–242 (in Jpn)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hirayama, C., Okumura, M., Tanikawa, K. et al. A multicenter randomized controlled clinical trial of Shosaiko-to in chronic active hepatitis. Gastroenterol Jpn 24, 715–719 (1989). https://doi.org/10.1007/BF02774173
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02774173